389 related articles for article (PubMed ID: 35844604)
1. Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications.
Di Vito C; Calcaterra F; Coianiz N; Terzoli S; Voza A; Mikulak J; Della Bella S; Mavilio D
Front Immunol; 2022; 13():888248. PubMed ID: 35844604
[TBL] [Abstract][Full Text] [Related]
2. Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2.
Saini P; Adeniji OS; Bordoloi D; Kinslow J; Martinson J; Parent DM; Hong KY; Koshy J; Kulkarni AJ; Zilberstein NF; Balk RA; Moy JN; Giron LB; Tracy RP; Keshavarzian A; Muthumani K; Landay A; Weiner DB; Abdel-Mohsen M
mBio; 2023 Feb; 14(1):e0339322. PubMed ID: 36728420
[TBL] [Abstract][Full Text] [Related]
3. Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies.
Market M; Angka L; Martel AB; Bastin D; Olanubi O; Tennakoon G; Boucher DM; Ng J; Ardolino M; Auer RC
Front Immunol; 2020; 11():1512. PubMed ID: 32655581
[TBL] [Abstract][Full Text] [Related]
4. NK cells in COVID-19-from disease to vaccination.
Hammer Q; Cuapio A; Bister J; Björkström NK; Ljunggren HG
J Leukoc Biol; 2023 Oct; 114(5):507-512. PubMed ID: 36976012
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells in antiviral immunity.
Björkström NK; Strunz B; Ljunggren HG
Nat Rev Immunol; 2022 Feb; 22(2):112-123. PubMed ID: 34117484
[TBL] [Abstract][Full Text] [Related]
6. Early expansion of activated adaptive but also exhausted NK cells during acute severe SARS-CoV-2 infection.
Claus M; Pieris N; Urlaub D; Bröde P; Schaaf B; Durak D; Renken F; Watzl C
Front Cell Infect Microbiol; 2023; 13():1266790. PubMed ID: 37712059
[TBL] [Abstract][Full Text] [Related]
7. Harnessing Memory NK Cell to Protect Against COVID-19.
Soleimanian S; Yaghobi R
Front Pharmacol; 2020; 11():1309. PubMed ID: 32973527
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D.
Lee MJ; Leong MW; Rustagi A; Beck A; Zeng L; Holmes S; Qi LS; Blish CA
Cell Rep; 2022 Dec; 41(13):111892. PubMed ID: 36543165
[TBL] [Abstract][Full Text] [Related]
9. An Evaluation of Type 1 Interferon Related Genes in Male and Female-Matched, SARS-CoV-2 Infected Individuals Early in the COVID-19 Pandemic.
Huecksteadt TP; Myers EJ; Aamodt SE; Trivedi S; Warren KJ
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543837
[TBL] [Abstract][Full Text] [Related]
10. Guardians of immunity: NK cell-mediated defense in COVID-19 and post-COVID scenarios.
Petrov S; Taskov H; Murdjeva M
Folia Med (Plovdiv); 2024 Feb; 66(1):12-18. PubMed ID: 38426460
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies.
Fielding CA; Sabberwal P; Williamson JC; Greenwood EJD; Crozier TWM; Zelek W; Seow J; Graham C; Huettner I; Edgeworth JD; Price DA; Morgan PB; Ladell K; Eberl M; Humphreys IR; Merrick B; Doores K; Wilson SJ; Lehner PJ; Wang ECY; Stanton RJ
Elife; 2022 May; 11():. PubMed ID: 35587364
[TBL] [Abstract][Full Text] [Related]
12. Innate lymphoid cells (ILC) in SARS-CoV-2 infection.
Kumar A; Cao W; Endrias K; Kuchipudi SV; Mittal SK; Sambhara S
Mol Aspects Med; 2021 Aug; 80():101008. PubMed ID: 34399986
[TBL] [Abstract][Full Text] [Related]
13. Defining the role of natural killer cells in COVID-19.
Lee MJ; Blish CA
Nat Immunol; 2023 Oct; 24(10):1628-1638. PubMed ID: 37460639
[TBL] [Abstract][Full Text] [Related]
14. NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19.
Bergantini L; d'Alessandro M; Cameli P; Cavallaro D; Gangi S; Cekorja B; Sestini P; Bargagli E
Cells; 2021 Nov; 10(11):. PubMed ID: 34831404
[TBL] [Abstract][Full Text] [Related]
15. Innate immune responses to SARS-CoV-2.
Dawoodi S; Rizvi SAA; Zaidi AK
Prog Mol Biol Transl Sci; 2024; 202():127-154. PubMed ID: 38237984
[TBL] [Abstract][Full Text] [Related]
16. Innate Immune Response to SARS-CoV-2 Infection: From Cells to Soluble Mediators.
Ricci D; Etna MP; Rizzo F; Sandini S; Severa M; Coccia EM
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209845
[TBL] [Abstract][Full Text] [Related]
17. Host cell-intrinsic innate immune recognition of SARS-CoV-2.
Madden EA; Diamond MS
Curr Opin Virol; 2022 Feb; 52():30-38. PubMed ID: 34814102
[TBL] [Abstract][Full Text] [Related]
18. Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms.
Brown B; Ojha V; Fricke I; Al-Sheboul SA; Imarogbe C; Gravier T; Green M; Peterson L; Koutsaroff IP; Demir A; Andrieu J; Leow CY; Leow CH
Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851285
[TBL] [Abstract][Full Text] [Related]
19. The Immunopathobiology of SARS-CoV-2 Infection.
Patel M; Shahjin F; Cohen JD; Hasan M; Machhi J; Chugh H; Singh S; Das S; Kulkarni TA; Herskovitz J; Meigs DD; Chandra R; Hettie KS; Mosley RL; Kevadiya BD; Gendelman HE
FEMS Microbiol Rev; 2021 Nov; 45(6):. PubMed ID: 34160586
[TBL] [Abstract][Full Text] [Related]
20. Systems analysis of innate and adaptive immunity in Long COVID.
Peluso MJ; Abdel-Mohsen M; Henrich TJ; Roan NR
Semin Immunol; 2024 Mar; 72():101873. PubMed ID: 38460395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
